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Abstract
Focal adhesion kinase (FAK) transduces cell adhesion to the extracellular matrix into proliferative signals. We
show that FAK overexpression induced proliferation in endothelial cells, which are normally growth arrested
by limited adhesion. Interestingly, displacement of FAK from adhesions by using a FAK−/− cell line or by
expressing the C-terminal fragment FRNK also caused an escape of adhesion-regulated growth arrest,
suggesting dual positive and negative roles for FAK in growth regulation. Expressing kinase-dead FAK-Y397F
in FAK−/− cells prevented uncontrolled growth, demonstrating the antiproliferative function of inactive FAK.
Unlike FAK overexpression–induced growth, loss of growth control in FAK−/− or FRNK-expressing cells
increased RhoA activity, cytoskeletal tension, and focal adhesion formation. ROCK inhibition rescued
adhesion-dependent growth control in these cells, and expression of constitutively active RhoA or ROCK
dysregulated growth. These findings demonstrate the ability of FAK to suppress and promote growth, and
underscore the importance of multiple mechanisms, even from one molecule, to control cell proliferation.
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Introduction
Cell proliferation in the multicellular organism is tightly con-
trolled through the cooperative efforts of numerous microenvi-
ronmental cues, including soluble growth factors and adhesion 
to the ECM. One potential point of integration between growth 
factor and adhesive signaling is in the focal adhesion (Schwartz 
and Ginsberg, 2002). Focal adhesions are structures that arise 
during the binding and clustering of integrins and serve to phys-
ically link the actin cytoskeleton to the underlying ECM. 
 Because they also contain numerous growth factor receptors 
and signaling proteins, focal adhesions have been proposed as 
localized sites where growth factor and adhesion signaling con-
verge (for reviews see Schwartz and Ingber, 1994; Sastry and 
Horwitz, 1996). FAK is a key effector in focal adhesion sig-
naling and a potential integrator of integrin- and growth factor–
mediated proliferative signaling. It is rapidly phosphorylated 
after integrin ligation (Guan et al., 1991; Burridge et al., 1992; 
Kornberg et al., 1992), which stimulates its kinase activity 
(Guan and Shalloway, 1992; Lipfert et al., 1992) and triggers 
the activation of signaling pathways involved in modulating 
 focal adhesions and their surrounding cytoskeletal structures 
(Parsons et al., 2000; Geiger et al., 2001).
Given its central role in adhesion signaling, it is not sur-
prising that numerous studies have demonstrated a regulatory 
role for FAK in cell cycle progression (Gilmore and Romer, 
1996; Zhao et al., 1998; Oktay et al., 1999). Such studies have 
shown that FAK overexpression drives G1/S phase cell cycle 
progression, whereas dominant–negative FAK mutants, such as 
FRNK, or anti-FAK antibodies block the cell cycle at the G1/S 
phase boundary (Gilmore and Romer, 1996; Zhao et al., 1998; 
Nolan et al., 1999; Oktay et al., 1999). Mechanistically, FAK 
overexpression appears to enhance the transcriptional activa-
tion of cyclin D1 (Zhao et al., 1998). FAK appears to regu-
late the G1 cell cycle machinery through numerous signaling 
pathways. In endothelial cells (EC), FAK is required for sus-
tained ERK activity downstream of VEGF stimulation (Hood 
et al., 2003).  Additionally, FAK regulates the activity of the 
Rho GTPase RhoA, which is also required for sustained ERK 
signaling (Danen et al., 2000; Ren et al., 2000; Welsh et al., 
2001).  Importantly, although FAK signaling clearly modulates 
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increased RhoA activity, cytoskeletal tension, and focal 
adhesion formation. ROCK inhibition rescued adhesion-
dependent growth control in these cells, and expression of 
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and promote growth, and underscore the importance of 
multiple mechanisms, even from one molecule, to control 
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cell  cycle progression, it does not appear to be required, as 
FAK−/− cells and cells treated with FAK RNAi still prolif-
erate (Ilic et al., 1995; Duxbury et al., 2003). Thus, the role of 
FAK in adhesion-regulated proliferation is likely to be multi-
faceted, and may depend on the adhesive context in which FAK 
signaling occurs.
To conceptually dissect how FAK might regulate  adhesion-
dependent proliferation, it is necessary to defi ne adhesion 
more precisely. Although cell adhesion is initiated by integrin 
binding to ECM ligands, it involves numerous other processes, 
such as integrin clustering, focal adhesion maturation, and cell 
spreading and fl attening against the substrate, each of which ap-
pears to be involved in regulating proliferation. Integrin ligation 
and clustering, although necessary for the proliferation of ad-
herent cells, is not suffi cient to support cell cycle progression. 
Proliferation also requires that the ECM allows cells to physi-
cally spread against the substrate; cells that are prevented from 
spreading or fl attening against the ECM are growth arrested 
(Chen et al., 1997). Interestingly, these changes in cell spread-
ing appear to be required for RhoA-mediated cytoskeletal ten-
sion and focal adhesions to develop (Chen et al., 2003; Tan 
et al., 2003), and inhibiting cytoskeletal tension and focal adhe-
sion formation appear to abolish proliferation in spread cells 
(Bohmer et al., 1996; Huang et al., 1998). Thus, changes in in-
tegrin ligation, cell spreading, cytoskeletal tension, and focal 
adhesion formation are clearly interdependent, and have all 
been implicated in growth regulation. Because of the prominent 
role of FAK in multiple aspects of the adhesive processes, in-
cluding focal adhesion development (Lewis and Schwartz, 
1995), spreading (Gilmore and Romer, 1996; Richardson et al., 
1997), and mechanical tension (Burridge and Chrzanowska-
Wodnicka, 1996), FAK may serve as a critical point of integra-
tion for transducing each of these adhesive processes into a 
coordinated biological response, such as proliferation.  However, 
despite the involvement of FAK in the various aspects of adhe-
sion, how FAK functions to regulate proliferation under differ-
ent adhesive contexts is ill defi ned.
By examining the proliferative effects of modulating FAK 
in different adhesive contexts, we have found that FAK plays 
a dual role in regulating growth. In contexts of high adhesion, 
FAK activity and proliferation are high. In low ECM ligand or 
low cell-spreading contexts, normally growth-arrested cells can 
be induced to proliferate by activating FAK. Surprisingly, the 
growth inhibition in these low adhesive states is mediated by 
inactive FAK, as loss of FAK in either FAK−/− cells or FRNK-
expressing cells dysregulated adhesion-dependent growth control. 
Full-length, kinase-dead FAK-Y397F, in contrast to FRNK, 
rescued adhesion-dependent growth regulation, suggesting the 
possibility that the N terminus of FAK may mediate the growth 
inhibitory function. The uncontrolled growth after loss of FAK 
was mediated through an increase in RhoA signaling and cyto-
skeletal tension. Thus, FAK appears to transduce both high 
adhesive signals, to stimulate proliferation, and low adhesive 
signals, to arrest growth. This dual nature highlights FAK as a 
central control point for growth regulation, and underscores its 
critical role in integrating the multiple adhesive, mechanical, 
and biochemical functions of focal adhesions.
Results
FAK regulates adhesion-mediated 
proliferation
To begin to explore the role of FAK in regulating proliferation, 
we fi rst established the dependence of bovine pulmonary artery 
EC proliferation on growth factors and adhesion. Cells were 
G0 synchronized at confl uence, replated under various growth 
factor or adhesive conditions, and assayed for proliferation by 
tracking BrdU incorporation as a marker of S phase entry. As 
expected, when ECs were exposed to low serum (0.01%) or 
grown on surfaces coated with a low density of fi bronectin 
Figure 1. FAK regulates adhesion-mediated 
proliferation. (A–D) Graph of the percentage 
of ECs in S phase, measured by the incorpora-
tion of BrdU (A), immunoﬂ uorescence images 
of vinculin (B and C), and a graph of the aver-
age focal adhesion area per cell (D) in cells 
cultured for 24 h in 5 or 0.01% serum, on sur-
faces coated with 25 μg/ml ﬁ bronectin. (E–H) 
Graph of the percentage of ECs in S phase (E), 
immunoﬂ uorescence images of vinculin 
(F and G), and graph of average focal adhesion 
area per cell (H) in cells cultured in 5% serum 
on surfaces coated with 25, 0.5, or 0.1 μg/ml 
 ﬁ bronectin. (I–K) Graph of the percentage of 
GFP- or FAK-overexpressing ECs that enter S 
phase when cultured on 25 μg/ml ﬁ bronectin-
coated surfaces in 5% serum (I), on 25 μg/ml 
ﬁ bronectin-coated surfaces in 0.01% serum (J), 
or on 0.1 μg/ml ﬁ bronectin-coated surfaces in 
5% serum (K). (L) Average area of cells when 
cultured in 5% serum and on surfaces coated 
with 25, 0.5, or 0.1 μg/ml ﬁ bronectin. Data 
is expressed ± SEM for three independent 
 experiments. *, P < 0.05. Bar, 20 μm.
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(0.1 μg/ml), cell proliferation was inhibited compared with 
cells grown in high serum (5%) or on surfaces coated with a 
high density of fi bronectin (25 μg/ml; Fig. 1, A and E). To ex-
amine whether the serum or fi bronectin concentrations affected 
focal adhesion formation, we analyzed vinculin distribution 
by immunofl uorescence. Whereas cells grown in high serum 
formed large, well-defi ned focal adhesions (Fig. 1 B), cells cul-
tured in low serum showed reduced focal adhesion number and 
area (Fig. 1, C and D). Fibronectin concentration affected focal 
adhesion formation to an even greater extent (Fig. 1, F–H). This 
correlation between proliferation and focal adhesion area in 
both serum- and adhesion-regulated growth suggested the pos-
sibility that FAK might be involved in both growth factor– and 
adhesion-mediated proliferation. To begin to explore this possi-
bility, we examined whether overexpression of FAK could over-
come the proliferation block caused by either low serum or 
low-density fi bronectin. G0-synchronized ECs were transduced 
with a recombinant adenovirus containing wild-type FAK, re-
sulting in FAK overexpression and constitutive autophosphory-
lation. FAK overexpression did not rescue the growth arrest 
caused by low serum and did not affect proliferation induced by 
high serum (Fig. 1, I and J). In contrast, cells plated on low-
density fi bronectin dramatically increased proliferation upon 
FAK overexpression (Fig. 1 K). These fi ndings suggest the pos-
sibility that FAK mediates the proliferative signals initiated by 
adhesion, but not by growth factors.
Cell adhesion involves many different steps, including 
integrin ligation and clustering and cell spreading and fl atten-
ing against the substrate (Chen et al., 1997). Decreasing fi bro-
nectin density not only decreased integrin clustering and focal 
adhesion formation, but also impaired cell spreading (Fig. 1 L). 
Because changes in cell spreading can directly regulate cell 
proliferation, despite the presence of excess extracellular 
matrix, we examined whether FAK is also involved in the regu-
lation of cell proliferation by changes in cell shape. To specifi -
cally modulate cell shape without altering fi bronectin density 
and integrin clustering, we used microcontact printing to gen-
erate micrometer-scale islands coated with a high density of 
fi bronectin, separated by nonadhesive regions such that the 
size of the islands dictated the degree of cell spreading. ECs 
seeded onto small, square islands (625 μm2) remained rela-
tively unspread, whereas ECs seeded onto uniformly coated 
surfaces spread to an average of 2,000 μm2 (Fig. 2, A and B). 
 Measurement of S phase entry under these conditions dem-
onstrated that the unspread cells could not proliferate (Fig. 
2 C). Substantially fewer and smaller focal adhesions formed 
in the growth-arrested unspread cells compared with spread 
controls (Fig. 2, D–F), suggesting the possibility that altera-
tions in focal adhesion architecture and/or signaling may also 
underlie proliferative regulation by cell spreading. To examine 
whether cell spreading specifi cally affected FAK activity, we 
measured FAK phosphorylation at tyrosine 397 in these cells. 
At early time points after replating, attachment, spreading, 
and FAK phosphorylation at Y397 was similar between spread 
and unspread cells (Fig. 2 G). At later time points, unspread 
cells showed progressively lower FAK phosphorylation while 
spread cells transiently increased FAK activation (Fig. 2 G). 
These data suggested the possibility that FAK signaling may 
be fundamentally different in spread versus unspread cells and 
that FAK may be directly involved in the proliferation response 
of cells to changes in cell spreading.
To explore this possibility, cells were transduced with 
wild-type FAK adenovirus and cultured on the micropatterned 
substrates. FAK overexpression increased proliferation as com-
pared with a GFP control (Fig. 2 H). Because FAK overexpres-
sion appears to rescue proliferation that was inhibited both by 
low-density fi bronectin and by reduced cell spreading, but not 
by low serum, FAK appears to be specifi cally involved in pro-
liferative signals mediated by adhesive cues. In physiologic 
settings, however, the primary mode of adhesion-mediated 
arrest in ECs is mediated by confl uence of the monolayer, not 
through changes in ligand density or cell area. To test whether 
FAK signaling is involved in confl uence-induced arrest, we 
expressed FAK in monolayer cultures. FAK overexpression 
increased proliferation in cells arrested by traditional contact 
inhibition (Fig. 2 I). Together these studies suggest that FAK 
may be involved in several of the means by which adhesion 
regulates proliferation.
Figure 2. FAK regulates shape-mediated proliferation. (A and B) F-actin 
(red) and DAPI (blue) stain of ECs cultured on surfaces uniformly coated 
with 25 μg/ml ﬁ bronectin (Spread; A) or onto 625-μm2 islands of ﬁ bro-
nectin (Unspread; B). (C) Graph of the percentage of spread versus un-
spread cells in S phase measured by the incorporation of BrdU. (D and E) 
Immunoﬂ uorescence images of vinculin in cells cultured on surfaces uni-
formly coated with 25 μg/ml ﬁ bronectin (D) or onto 625-μm2 islands of 
 ﬁ bronectin (E). (F) Graph of the average focal adhesion area per spread 
versus unspread cell. (G) Western blot of phospho–Y397-FAK and total 
FAK in spread (S) versus unspread (U) cells at 30, 60, 90, 180, and 360 min 
after replating, and a graph showing phospho-FAK normalized to total 
FAK. (H and I) Graph of the percentage of GFP- or FAK-overexpressing ECs 
that enter S phase when cultured on 625-μm2 islands of ﬁ bronectin (H) or 
in a monolayer (I). Data is expressed ± SEM for three independent 
 experiments. *, P < 0.05. Bar, 20 μm.
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Loss of FAK signaling causes constitutive 
cell proliferation
The stimulation of proliferation by FAK overexpression suggests 
at least two possible models for adhesion-regulated proliferation.
The fi rst, and predominantly accepted, model is that FAK 
 activity triggered by adhesion stimulates proliferation (Gilmore 
and Romer, 1996; Zhao et al., 1998). A second, equally plau-
sible model is that inactive FAK in cells with limited adhesion or 
spreading inhibits proliferation. To begin to address these pos-
sibilities, we examined the proliferative response of cells com-
pletely lacking FAK. G0-synchronized FAK−/− mouse embryo 
fi broblasts were seeded onto micropatterned islands of various 
sizes or onto unpatterned surfaces, where the cells ranged in 
size from 625 μm2 to fully spread (2,500 μm2; Fig. 3 A). 
Well-spread FAK−/− cells proliferated maximally, as expected 
(Fig. 3 B). Surprisingly, unspread FAK−/− cells also prolifer-
ated (Fig. 3 B), indicating that loss of FAK may have eliminated 
adhesion-dependent proliferative control mechanisms. To address 
this, we examined the effect of reexpressing FAK on proliferation.
FAK reexpression to endogenous levels, which resulted in 
the rescue of the spreading-dependent FAK autophosphorylation 
seen in ECs (Fig. 3 C), inhibited proliferation only in unspread 
cells, rescued normal adhesion-dependent growth control, and 
confi rmed that the loss of growth control was specifi c to loss 
of FAK (Fig. 3 B). The constitutive proliferation in FAK−/− 
cells suggests that one important and previously undescribed 
func tion of FAK is to limit proliferation in low adhesive condi-
tions. However, although the micropatterned substrates provide 
a pre cise quantitative method to control adhesion, fi broblasts 
are typically adhesion-regulated in a 3D  microenvironment. 
In this context, we cultured the FAK−/− and FAK- reexpressing 
fi broblasts in 3D collagen gels, where cell proliferation is 
often  suppressed. Consistent with the micropatterning studies, 
FAK−/− cells continued to proliferate at higher levels in the 
collagen gel, whereas FAK reexpression rescued growth sup-
pression (Fig. 3 D). As with ECs, highly overexpressing FAK to 
severalfold above endogenous levels in the FAK-reexpressing
fi broblasts increased proliferation in unspread conditions 
(unpublished data). Thus, it appears that a delicate balance of 
FAK expression is needed for proliferative control.
Because the FAK−/− and FAK-reexpressing cell lines 
are immortalized, and known compensatory changes in sig-
naling pathways might have affected our interpretation of the 
proliferative effect, we next examined whether the same in-
hibitory role of FAK in proliferation might operate in normal 
nonimmortalized cells. To address this question, we generated 
recombinant adenoviruses to express the well-characterized 
dominant–negative FAK construct FRNK; consisting of amino 
acids 668–1,053 of wild-type FAK (Schaller et al., 1993), 
as well as a shorter C-terminal construct of FAK contain-
ing  only the focal adhesion–targeting (FAT) domain (amino 
acids 919–1,053; Prutzman et al., 2004). We also generated an 
 autophosphorylation-defective FAK mutant (FAK-Y397F) in 
adenovirus (Schaller et al., 1994). Infecting cells with the FAK 
adenovirus causes overexpression of FAK that is highly phos-
phorylated (Fig. 4 A), whereas expression of FRNK, FAT, and 
FAK-Y397F down-regulates endogenous FAK phosphorylation 
(Fig. 4 A). Previous studies have shown that FRNK and FAT 
displace endogenous FAK from adhesions (Richardson and 
 Parsons, 1996). We have confi rmed these fi ndings in our  system. 
Figure 3. FAK has a growth inhibitory role. (A and B) F-actin stain (A) and graph of the percentage of cells in S phase (B) for FAK−/− cells and FAK-
 reexpressing cells cultured on different-sized islands of ﬁ bronectin. (C) Western blot of phospho–Y397-FAK and total FAK in FAK−/− and FAK-reexpressing 
cells in spread (substrates coated with 25 μg/ml ﬁ bronectin; S) or unspread (substrates patterned with 625-μm2 islands of ﬁ bronectin; U) conditions. 
(D) Graph of the percentage of FAK−/− and FAK-reexpressing cells in S phase when cultured in a 3D collagen gel. All data is expressed as ± SEM for 
three independent experiments. *, P < 0.05 between FAK−/− or FAK-reexpressing cells. Bar, 10 μm.
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Cells expressing GFP, FRNK, FAK, and FAK-Y397F were frac-
tionated into Triton X-100–soluble and –insoluble pools and 
blotted for FAK. FRNK decreased total FAK in the insoluble pool 
and phosphorylated FAK to nearly undetectable levels (Fig. 4 B). 
Similarly, FRNK expression also decreased the amount of 
 total FAK (and phosphorylated FAK) that coimmunoprecipi-
tated with paxillin (unpublished data). Because FRNK, FAT, 
and FAK-Y397F all contain the C-terminal FAT region, lack 
kinase activity, compete to displace endogenous full-length 
FAK from the focal adhesion, and thereby decrease endogenous 
FAK phosphorylation, we postulated that expression of these 
dominant–negative mutants might have the same proliferative 
effects as seen in the FAK−/− cells. To examine this possi-
bility, ECs were transduced with recombinant adenoviruses to 
express FRNK, FAT, or FAK-Y397F, cultured on small islands 
of fi bronectin, and assayed for proliferation by BrdU incorpora-
tion. As compared with GFP and FAK, as negative and positive 
controls, respectively, FRNK increased proliferation (Fig. 4 C). 
Expressing the FAT construct also relieved the proliferation ar-
rest induced by restricted adhesion. Interestingly, FAK-Y397F 
did not induce cell proliferation. FAK or FRNK expression 
also released cells from growth arrest in monolayer cultures, but 
did not rescue proliferation in cells placed in suspension 
 (unpublished data). Although the various FAK constructs in-
creased proliferation relative to a GFP control in conditions of 
low adhesion, cell proliferation in a highly adhesive environment 
was not dramatically affected by expression of the FAK con-
structs (Fig. 4 D). Although the stimulatory effects of wild-type 
FAK expression on proliferation is consistent with previous 
studies (Gilmore and Romer, 1996; Zhao et al., 1998), the loss of 
 adhesion-dependent proliferative control in FAK−/−, FRNK-, 
or FAT-expressing cells suggests that, in addition,  inactive 
FAK might function to actively inhibit proliferation. FRNK and 
FAT may relieve this inhibition by displacing inactive FAK from 
the adhesion, whereas FAK phosphorylation might do so via a 
 different mechanism. In support of this hypothesis, overexpress-
ing the inactive FAK-Y397F in FAK−/− cells, like wild-type 
FAK, rescued adhesion-mediated growth control (Fig. 4 E). 
 Together, these results uncover a previously undescribed func-
tion of FAK as a negative growth regulator, and, in particular, 
support a model whereby inactive FAK within adhesions 
 inhibits proliferation.
As an initial characterization of the proliferative mecha-
nisms induced by FAK or FRNK, we examined the role of 
downstream MAPK and Src signaling pathways. Although most 
extracellular signals regulate proliferation through the regula-
tion of MAPK-dependent signals in the G1 phase of the cell cycle, 
others have been reported to occur at different levels (Brooks 
et al., 1997). Because FAK is known to have a very close asso-
ciation with the nonreceptor tyrosine kinase Src, which is 
 another important proliferative signaling protein, we also exam-
ined whether FAK- or FRNK-induced proliferation were 
Src dependent. G0-synchronized cells were transduced with 
 adenoviruses to express FAK, FRNK, or GFP, seeded onto 
625-μm2 islands of fi bronectin, and treated with 10 μM of the 
MEK inhibitor UO126, 25 μM JNK inhibitor I, 1 μM of the 
p38 inhibitor SB203580, or 1 μM of the Src inhibitor PP2. 
 Although inhibiting MEK or JNK activity completely blocked 
Figure 4. FRNK stimulates proliferation in low adhesive contexts. (A) Western blots of GFP-, FAK-, FRNK-, or FAK-Y397F-overexpressing ECs in spread 
(substrates coated with 25 μg/ml ﬁ bronectin) or unspread (substrates patterned with 625-μm2 islands of ﬁ bronectin) conditions and probed for phospho–
Y397-FAK, total FAK, or GAPDH. (B) Western blot of phospho–Y397-FAK and total FAK in the Triton X-100–insoluble fraction of unspread ECs expressing 
GFP (control), FRNK, FAK, or FAK-Y397F. β–actin is shown as a loading control. (C and D) Graph of the percentage of GFP-, FAK-, FRNK-, FAT-, or FAK-
Y397F–overexpressing ECs entering S phase when cultured on 625-μm2 islands of ﬁ bronectin (C) or on substrates coated with 25 μg/ml ﬁ bronectin (D). 
(E) Graph of the percentage of FAK−/− cells, FAK-reexpressing cells, and FAK−/− cells overexpressing FAK-Y397F in S phase when cultured in spread 
or unspread conditions. (F) Graph of the percentage of GFP-, FAK-, or FRNK-overexpressing ECs entering S phase when cultured on 625-μm2 islands of 
 ﬁ bronectin and treated with either 10 μM UO126 or 1 μM PP2. All data is expressed as ± SEM for three independent experiments. *, P < 0.05 with GFP 
control or FAK−/− cells. #, P < 0.05 with untreated control.
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FAK- and FRNK-induced proliferation, the p38 inhibitor had 
no effect (Fig. 4 F and not depicted). Interestingly, FAK- and 
FRNK- expressing cells responded differently to PP2 treatment. 
The FAK-mediated increase in cell proliferation was blocked by 
inhibiting Src, but FRNK-mediated proliferation was not (Fig. 
4 F). These fi ndings suggest a divergence of signaling pathways 
between the proliferative effects mediated by FAK activation 
and those mediated by loss of FAK. Because the dysregulation 
of adhesion-dependent growth control by FAK down-regulation 
has not been previously described, we chose to further investi-
gate the molecular mechanisms underlying this process.
FAK regulates proliferation through RhoA
Our initial studies indicated that focal adhesions are signifi cantly 
larger in conditions that promoted proliferation than in those 
that arrested growth. Therefore, we explored whether the size of 
 focal adhesions in spread and unspread cells was also affected by 
the expression of FAK, FRNK, FAT, and FAK-Y397F. FRNK and 
FAT expression both dramatically increased focal adhesion area 
in unspread cells, but not in well-spread cells (Fig. 5, A and B),
mirroring their effects on proliferation. FAK and the Y397F 
mutant increased focal adhesion size, but to a lesser extent. Focal 
adhesion size has been shown to depend on RhoA signaling 
(Ridley and Hall, 1992; Nobes and Hall, 1995), suggesting 
that changes in FAK signaling may modulate RhoA activity. 
To test this possibility, we examined RhoA activity in FRNK-, 
FAK-, or FAK-Y397F–expressing ECs. Cells were transduced 
with recombinant adenoviruses, replated onto 625-μm2 square 
patterns or onto surfaces uniformly coated with fi bronectin, 
and lysed 6 h after replating. Using the RhoA pull-down assay 
to measure GTP-bound RhoA, we found that FRNK expres-
sion increased RhoA activity compared with GFP-expressing 
control cells both in spread and unspread conditions, whereas 
FAK or FAK-Y397F expression had little to no effect (Fig. 6 A). 
Likewise, the FAK−/− cells showed higher RhoA activity 
than FAK-reexpressing cells (Fig. 6 B). To address whether 
RhoA was directly involved in the dysregulation of proliferative 
control induced by loss of FAK signaling, we examined the ef-
fects of inhibiting the RhoA effector ROCK in FRNK-expressing 
cells. ROCK inhibition with 50 μM Y-27632 blocked the 
FRNK-induced increase in proliferation in unspread cells (Fig. 
6 C). This effect was specifi c to the release of growth inhibition 
by FRNK, as Y-27632 treatment did not inhibit proliferation 
rates in well-spread cells (Fig. 6 D). Similarly, FAK−/− cells 
treated with Y-27632 also regained adhesion-dependent growth 
control. That is, cell proliferation was low in unspread cells 
and high in spread cells in the presence of the ROCK inhibitor 
(Fig. 6, E and F). Collectively, these data suggest a signaling path-
way whereby lack of FAK or displacing endogenous FAK from 
focal adhesions causes an increase in RhoA activity, and this 
increase, in turn, is required for loss of the growth control nor-
mally observed in low adhesive conditions.
FAK regulates proliferation through RhoA-
mediated changes in cytoskeletal tension
To determine whether changes in RhoA signaling are suffi cient 
to directly affect proliferation, we overexpressed a constitu-
tively active form of RhoA (RhoA-V14) in unspread ECs. 
RhoA-V14 dramatically increased stress fi ber formation 
(Fig. 7 A) and was suffi cient to overcome the spreading-regulated 
Figure 5. FRNK and FAT induce focal adhesion growth in unspread cells. 
(A) Immunoﬂ uorescence images of vinculin in GFP-, FAK-, FRNK-, FAT-, or 
FAK-Y397F–overexpressing ECs cultured for 24 h onto 625-μm2 islands of 
ﬁ bronectin (Unspread) or surfaces uniformly coated with 25 μg/ml ﬁ bro-
nectin (Spread). Graph of the average focal adhesion area of GFP-, FAK-, 
FRNK-, FAT-, or FAK-Y397F–expressing ECs when cultured in spread versus 
unspread conditions (B). Data is expressed ± SEM. Approximately 150 
cells were analyzed in each condition; *, P < 0.05 with GFP control; 
#, P < 0.05 as compared with FRNK or FAT conditions. Bar, 10 μm.
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block in proliferation (Fig. 7 B). High RhoA also released cells 
from proliferation arrest induced by confl uence (unpublished 
data). This effect was mediated through the RhoA effector 
ROCK, as treatment with Y-27632 abrogated the RhoA-V14–
induced proliferation (Fig. 7 B). This ROCK activity was not 
only necessary but also suffi cient to induce proliferation, as ex-
pression of a constitutively active ROCK (ROCK-∆3) also by-
passed the shape-dependent control mechanism (Fig. 7 D). As 
with RhoA-V14 overexpression, ROCK-∆3 overexpression had 
no effect in well-spread cells (Fig. 7, C and E).
One important consequence of RhoA and ROCK sig-
naling is in mediating changes in myosin-regulated cytoskeletal 
tension (Amano et al., 1996; Kimura et al., 1996; Ishizaki et al., 
1997). To address whether FRNK-induced signaling altered 
 focal adhesion structure and proliferation via RhoA-mediated 
changes in cytoskeletal tension, we assessed myosin phosphory-
lation in cells expressing FRNK. FRNK expression dramatically 
increased the amount of phosphomyosin compared with GFP 
controls (Fig. 7 F). Although this suggests that FRNK might be 
functioning to increase cytoskeletal tension in unspread cells, 
myosin phosphorylation is not always associated with the de-
velopment of tension. To directly measure the tension transmit-
ted across the focal adhesion onto the underlying substrate, we 
used a previously described microfabricated force sensor (Tan 
et al., 2003), consisting of an array of vertically placed elas-
tomeric microneedles. These microneedles report the traction 
force exerted by cells on the underlying substrate. Thus, we 
directly measured the tension generated in unspread cells ex-
pressing FAK, FRNK, FAK-Y397F, or a GFP control. Notably, 
only FRNK expression increased traction force (Fig. 7, G and H). 
FAK expression showed no differences in tension, whereas ex-
pression of FAK-Y397F decreased tension.  Collectively, these 
data support a novel role for FAK in growth control, in which 
loss of FAK signaling can induce RhoA-mediated cytoskeletal 
tension, leading to the loss of adhesion-dependent control of 
cell proliferation.
Discussion
In this study, we demonstrate that FAK plays a key role in the 
regulation of proliferation by cell adhesion, whether modulated 
by ECM density, cell spreading, confl uence, or 3D culture. FAK 
overexpression has been shown to increase proliferation in pre-
vious studies (Gilmore and Romer, 1996; Zhao et al., 1998). We 
fi nd that FAK exerts not only stimulatory but also inhibitory ef-
fects on proliferation. The inhibitory function of FAK is lost 
in FAK−/− cells and, importantly, rescued when FAK is 
 reexpressed. Interestingly, expressing the C-terminal fragments 
of FAK (FRNK or FAT) also dysregulated the inhibitory func-
tion of FAK, whereas the full-length, kinase-dead mutant (FAK-
Y397F) could rescue growth inhibition. These data suggest that 
the inhibitory function of FAK lies in its N-terminal domain. 
Given that we and others fi nd that FRNK and FAT displace 
 endogenous full-length FAK from focal adhesions (Richardson 
and Parsons, 1996), these C-terminal constructs might interfere 
with FAK function by competitively inhibiting the targeting of 
cellular FAK to the focal adhesion, suggesting the interesting 
possibility that a pool of inactive FAK may normally function to 
inhibit proliferation through these interactions, and suggests 
a model whereby FAK acts within adhesions as a graded sensor 
that transduces  adhesive signals to regulate the cell cycle (Fig. 8). 
Figure 6. FRNK expression increases RhoA activity. (A) RhoA-GTP and 
total RhoA levels in GFP-, FRNK-, FAK-, or FAK-Y397F–expressing ECs. 
(B) RhoA-GTP and total RhoA levels in FAK−/− or FAK-reexpressing cells. 
(C and D) Graph of the percentage of GFP- or FRNK-overexpressing ECs 
that enter S phase when cultured on 625-μm2 islands of ﬁ bronectin (C) 
or on surfaces coated with 25 μg/ml ﬁ bronectin (D) and either untreated 
or treated with 50 μM Y-27632. (E and F) Graph of the percentage of 
FAK−/− or FAK-reexpressing cells that enter S phase when cultured on 
625-μm2 islands of ﬁ bronectin (E), or on surfaces coated with 25 μg/ml 
ﬁ bronectin (F) and either untreated or treated with 50 μM Y-27632. Data 
is expressed ± SEM for three independent experiments. +, P < 0.08 com-
pared with control; ++, P < 0.06 compared with control; *, P < 0.05 
between FRNK-overexpressing condition versus GFP control, or FAK−/− 
versus FAK-reexpressing cells; #, P < 0.05 between FRNK-induced prolifer-
ation or FAK−/− proliferation in untreated versus drug-treated samples.
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High FAK activation caused by high adhesion or by high 
FAK expression stimulates proliferation, whereas minimal 
 adhesion prevents FAK activation and yields inactive com-
plexes that inhibit proliferation. Interestingly, Moissoglu and 
Gelman (2003) observed an unexpected enhancement of soft 
agar colony formation in v-Src–transformed cells lacking FAK 
that was subsequently prevented by FAK reexpression, suggesting 
the possibility that FAK may play a negative regulatory role 
in transformation. Notably, this occurred in a low adhesive 
 environment. An alternative model for the proliferative response 
to both up- and down-regulation of FAK is the possibility that 
dynamic cycling of FAK activation and deactivation is required 
for growth inhibition. Repeated cycles of FAK phosphorylation 
and dephosphorylation appear to be important for cell migra-
tion, as both decreasing and increasing FAK activity reduce 
 migration (Yu et al., 1998; Angers-Loustau et al., 1999). Thus, 
both stimulatory and inhibitory roles for FAK may be an inher-
ent feature of its function in numerous cellular processes.
RhoA is a critical regulator of focal adhesion formation 
(Ridley and Hall, 1992; Nobes and Hall, 1995). Our results also 
demonstrate that RhoA plays a role in the dysregulation of 
growth control in cells lacking FAK. Both FRNK-expressing 
cells and FAK−/− cells exhibit high RhoA activity that appears 
to be both necessary and suffi cient for the observed proliferative 
effect (Fig. 8), supporting studies suggesting that RhoA pro-
motes cell cycle progression (Olson et al., 1998). Although we 
show that the RhoA effector ROCK is important in our system, 
RhoA-mediated mDia signaling also appears to be suffi cient to 
induce proliferation (Mammoto et al., 2004), suggesting that 
numerous RhoA signals may regulate growth. The mechanism 
by which FRNK and loss of FAK might up-regulate RhoA re-
mains to be defi ned, although a simple mechanism may be that 
FRNK opposes the suppression of RhoA activity by endoge-
nous FAK. The ability of FAK to down-regulate RhoA activity 
is well documented (Ren et al., 2000), and it has been shown 
that FAK may interact with the Rho GTPase-activating protein 
(GAP) GRAF (Hildebrand et al., 1996) and phosphorylate 
p190RhoGAP (Holinstat et al., 2006). It is possible that under 
different adhesive contexts, such as high or low ECM ligand 
density or high or low cell spreading, FAK may alter its interac-
tion with Rho GAPs or Rho GEFs and, thus, modulate RhoA 
activity and proliferation.
It has long been known that changes in cell shape and 
the associated changes in cytoskeletal tension are required for 
Figure 7. RhoA-mediated contractility rescues proliferation in unspread 
cells. (A) F-actin stain of GFP-, or RhoA-V14–overexpressing ECs cultured 
on 625-μm2 islands of ﬁ bronectin. (B and C) Graph of the percentage of 
GFP- or RhoA-V14–overexpressing ECs that enter S phase when cultured 
on 625-μm2 islands of ﬁ bronectin (B), or on surfaces uniformly coated with 
25 μg/ml ﬁ bronectin (C) and either untreated or treated with 50 μM 
Y-27632. (D and E) Graph of the percentage of GFP- or ROCK-∆3–over-
expressing ECs that enter S phase when cultured on 625-μm2 islands of 
 ﬁ bronectin (D), or on surfaces that were uniformly coated with 25 μg/ml 
 ﬁ bronectin (E), and either untreated or treated with 50 μM Y-27632. 
(F) Western blot and graph of phosphorylated myosin light chain in GFP- 
versus FRNK-expressing ECs, normalized to GAPDH. (G) A representative 
GFP-expressing EC cultured on the mPAD force sensors (red, ﬁ bronectin; 
green, GFP; blue, nucleus) and accompanying vector plot (green arrows 
indicate magnitude and the direction of force exerted on each underlying 
post). (H) Distribution plot of the magnitude of traction forces exerted by 
GFP-, FAK-, FRNK-, or FAK-Y397F–expressing ECs on mPADs. Data is ex-
pressed ± SEM for at least three independent experiments for proliferation 
and myosin phosphorylation data. For proliferation graphs, * denotes P < 
0.05 between RhoA-V14 or ROCK-∆3 versus GFP control and # denotes 
P < 0.05 between RhoA-V14 or ROCK-∆3–induced proliferation in un-
treated versus drug-treated samples. For force distribution plot, * denotes 
P < 0.05 between adenovirus condition as compared with GFP control. 
Bars, 10 μm.
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proliferation (Folkman and Moscona, 1978; Ingber, 1990; Chen 
et al., 1997; Huang et al., 1998). We show that FAK transduces 
cell shape into proliferative signals. Interestingly, although 
FAK has been implicated as a mechanosensor where increasing 
tension leads to FAK activation (Wang et al., 2001), we show 
that FAK also alters the cytoskeletal tension and forces experi-
enced at the adhesion. Expression of FRNK, through its effects 
on RhoA, increases myosin-based cytoskeletal tension, con-
fi rming earlier suggestions from the Parsons group that FRNK 
might increase cellular contractility (Martin et al., 2002). It has 
been previously observed that FRNK also increases focal adhe-
sion size (Giannone et al., 2002). Our fi ndings would suggest 
that these changes in focal adhesions are actually mediated by 
increased cytoskeletal tension, as focal adhesion maturation is 
induced by mechanical stress (Choquet et al., 1997; Balaban 
et al., 2001; Riveline et al., 2001). Thus, it appears that FAK 
both responds to and causes changes in mechanical force, and 
the latter links changes in cell adhesion to changes in cell me-
chanics and proliferation. These two reciprocal functions likely 
provide the mechanochemical feedback that is required for 
tightly integrating the mechanical and biochemical dynamics 
of cell adhesion.
The role of FAK in cell proliferation has implications for 
human physiology and pathology, where FAK protein over-
expression has been found in invasive human tumors (Owens 
et al., 1995; Kornberg, 1998). This has led to the suggestion that 
targeting FAK might reduce cancer proliferation, migration, 
and invasion. However, it is now clear that the model whereby 
FAK is strictly a stimulatory molecule for proliferation is over-
simplifi ed. In fact, FAK down-regulation can increase tumor cell 
motility, invasion, and metastasis (Ayaki et al., 2001; Lu et al., 
2001), and we speculate that it may also extend to include in-
creased proliferation. Thus, simply eliminating FAK function in 
cancer settings may be detrimental, and recognizing these addi-
tional layers in FAK function may reveal how cells can interpret 
complex adhesive contexts into a well-adapted response.
For many adherent cell types, both integrin ligation and 
cell spreading are required to support proliferation. Because fo-
cal adhesion architecture and, likely, the focal adhesion char-
acter are different in spread and unspread cells, it is probable 
that focal adhesions formed under these various adhesive or 
mechanical contexts transmit different signals, leading to po-
tentially divergent cellular behaviors. Importantly, FAK appears 
to be a central regulator of adhesion-mediated proliferation, 
whether signaled by spreading, confl uence, ligand density, or 
3D matrix architecture, where it can transduce both stimula-
tory and inhibitory proliferative signals. Understanding how 
this single molecule can play such a central role in many com-
plex interactions will uncover important insights into how cells 
navigate and respond to their adhesive and mechanical environ-
ments in physiologically meaningful ways.
Materials and methods
Cell culture and reagents
Bovine pulmonary artery ECs (VEC Technologies, Inc.) were cultured in 
low glucose DME containing 2 mM glutamine, 100 units/ml penicillin, 
100 μg/ml streptomycin, and 5% bovine serum (all from Invitrogen). ECs 
were maintained in a humidiﬁ ed 10% CO2 incubator. FAK−/− and FAK-
reexpressing mouse embryo ﬁ broblasts were a gift from S. Hanks (Vanderbilt 
University, Nashville, TN) and were cultured in DME containing 4,500 mg 
of D-glucose/ml, 2 mM glutamine, 100 units/ml penicillin, 100 μg/ml 
streptomycin, 0.25 μg of amphotericin B/ml (all from Invitrogen), and 
10% fetal bovine serum (Atlanta Biologicals) and were maintained at 37°C 
in a humidiﬁ ed 5% CO2 incubator. The following reagents were pur-
chased from the given suppliers: human ﬁ bronectin (Invitrogen); Y-27632 
 (Calbiochem), PP2 (Calbiochem), JNK inhibitor I, UO126 (Calbiochem), 
anti-vinculin clone hVin-1 (Sigma-Aldrich), TRITC-conjugated phalloidin 
(Sigma-Aldrich), anti-RhoA (Santa Cruz Biotechnology, Inc.), phospho-
Y397-FAK antibody (BioSource International), total FAK antibody (Cell Sig-
naling Technology), phospho-S18/S19 MLC antibody (Cell Signaling 
Technology), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
antibody (Abcam).
Immunocytochemistry, image analysis, and quantitative analysis 
of focal adhesions
For F-actin stains, cells were ﬁ xed with 4% paraformaldehyde in PBS. 
F-actin was visualized by incubating samples with ﬂ uorophore-conjugated 
Figure 8. Model for FAK modulation of 
 adhesion-regulated proliferation. (1) In con-
ditions that activate FAK (green FAK circles), 
such as high adhesive contexts or FAK over-
expression, FAK plays a stimulatory role in 
proliferation. (2) Endogenous FAK in low 
adhesive contexts, including low cell spread-
ing, low ﬁ bronectin density, and 3D gels, is 
largely inactive (black FAK circles) and inhibits 
proliferation. When inactive full-length FAK is 
displaced by FRNK or FAT (3), or is eliminated 
as in FAK−/− cells (4), RhoA is activated, 
leading to ROCK activation and the develop-
ment of cytoskeletal tension, creating a condi-
tion that is permissive for proliferation even in 
low adhesive  conditions. (5) The dominant–
 negative FAK-Y397F (black FAK circles with F) 
is sufﬁ cient to rescue the inhibitory function of 
FAK, but not its stimulatory role, in prolifera-
tion. Expression of constitutively active RhoA 
or ROCK (6) alone can induce proliferation in 
low adhesive contexts.
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phalloidin (Invitrogen). Quantitative analysis of focal adhesions was per-
formed as previously described (Nelson et al., 2004). In brief, cells were 
incubated for 1 min in ice-cold cytoskeleton buffer (50 mM NaCl, 150 mM 
sucrose, 3 mM MgCl2, 1 μg/ml aprotinin, 1 μg/ml leupeptin, 1 μg/ml 
pepstatin, and 2 mM PMSF), followed by 1 min in cytoskeleton buffer sup-
plemented with 0.5% Triton X-100. Detergent-extracted cells were ﬁ xed in 
4% paraformaldehyde in PBS, washed, and incubated with a primary anti-
body to vinculin (Sigma-Aldrich). After incubation with Alexa Fluor 594–
conjugated secondary antibodies (Invitrogen), quantitative microscopy of 
focal adhesion proteins was performed using a charge-coupled device 
camera (Orca; Hamamatsu) attached to an inverted microscope (model 
TE2000; Nikon) using a 100×, 1.4 NA, oil immersion objective with a 
400-ms exposure time at RT. Images were obtained and processed using 
IPLab software (Scanalytics); original images were ﬁ ltered and binarized 
to subtract background ﬂ uorescence, and then segmented with a threshold 
of 0.25 μm2 to quantify the area of individual adhesions. Approximately 
100–150 cells were analyzed per experimental condition.
Cell fractionation
Triton X-100 soluble and insoluble pools were generated by washing cells 
with ice-cold TBS, followed by a 5-min wash with Triton extraction buffer 
(50 mM NaCl, 150 mM sucrose, 3 mM MgCl2, 0.5% Triton X-100, 1 μg/ml 
aprotinin, 1 μg/ml leupeptin, 1 μg/ml pepstatin, and 2 mM PMSF). The 
soluble fraction was collected, mixed with Laemmli sample buffer, and 
boiled. The remaining Triton-insoluble fraction was collected by scraping 
directly into 1× Laemmli sample buffer and then boiled. Soluble and insol-
uble fractions were run on SDS-PAGE gels and blotted.
Culture and proliferation measurement of cells in collagen gel
3D collagen I gels were prepared by mixing M199 (Invitrogen), NaHCO3 
(0.035% wt/vol; Sigma-Aldrich), 10 mM Hepes buffer (Invitrogen), rat tail 
collagen I (BD Biosciences), and distilled water with the pH adjusted to 
7.4. Synchronized FAK−/− and FAK-reexpressing cells were seeded into 
a 2.4-mg/ml collagen gel at a concentration of 16,000 cells/ml followed 
by gelation at 37°C for 30 min. Cells were incubated for 22 h in the pres-
ence of radiolabeled thymidine (MP Biomedicals), after which the cells 
were lysed and DNA was precipitated with 16 M NaOH containing 
0.25% Triton X-100. Radioactivity counts were measured using a scintilla-
tion counter (Beckman Coulter). Blank collagen gels were used to measure 
background residual thymidine.
Micropatterned substrates
To generate stamps for microcontact printing of proteins, a prepolymer of 
poly(dimethylsiloxane) (PDMS; Sylgard 184; Dow Corning) was poured 
over a photolithographically generated master, as previously described 
(Chen et al., 1997). Stamps were immersed for 1 h in 50 μg/ml ﬁ bronectin, 
washed three times in water, and blown dry under nitrogen. Coated 
stamps were placed in conformal contact with a surface-oxidized PDMS-
coated glass coverslip. Stamped coverslips were immersed in 0.2% 
 Pluronic F127 (BASF) in PBS for 1 h and washed.
Adenovirus production
FAK, FRNK, FAT, FAK-Y397F, RhoA-V14, ROCK-∆3, and GFP recombinant 
adenoviruses were constructed using the AdEasy XL system (Stratagene) 
according to manufacturer’s instructions. RhoA cDNAs were obtained from 
M. Philips (New York University Medical Center, New York, NY) and 
P. Burbelo (Georgetown University, Washington, DC). ROCK cDNAs were 
obtained from S. Narumiya (Kyoto University, Kyoto, Japan). In brief, 
cDNAs were subcloned into the pShuttle-IRES-GFP1 vector, and then cotrans-
formed with the pADEASY1 plasmid. After homologous recombination, 
plasmids were used to transfect human embryonic kidney 293 cells. High 
titer preparations of recombinant adenovirus were generated by CsCl2 
density gradient centrifugation. In viral infection experiments, viral MOI re-
sulting in a transduction efﬁ ciency of at least 80% was added to cells.
Proliferation assays
ECs were G0 synchronized by holding the cells at conﬂ uence for 2 d. 
FAK−/− and FAK-reexpressing cells were synchronized by 60-h serum 
starvation. Cells were then trypsinized and replated in the presence of 
BrdU (GE Healthcare). Cells were ﬁ xed at 22 h and stained for BrdU 
incorporation using a monoclonal antibody directed against BrdU (GE 
 Healthcare). Cells were counterstained with Hoechst 33342 (Invitrogen).
RhoA activity assays
RhoA-GTP levels were measured by pull-down assay (Ren and Schwartz, 
2000). In brief, cells were washed with cold TBS, scraped into lysis buffer 
(25 mM Hepes, pH 7.5, 15 mM NaCl, 1% Igepal CA-630, 5 mM MgCl2, 
1 mM EDTA, 10% glycerol, 10 μg/ml aprotinin, 10 μg/ml leupeptin, 
10 μg/ml pepstatin, and 2 mM PMSF). Cleared lysates were incubated with 
30 μg GST–rhotekin-binding domain–agarose beads (Upstate Biotechnology) 
for 45 min at 4°C, centrifuged, washed, and eluted by boiling in 
SDS-PAGE buffer containing 5% β-mercaptoethanol for 5 min. RhoA was 
detected by Western blotting using a monoclonal antibody to RhoA (Santa 
Cruz Biotechnology, Inc.). The level of RhoA activity in different samples 
was determined by normalizing the amount of rhotekin-binding domain–
bound RhoA to the total amount of RhoA in cell lysates.
Western blots
Cells were washed in TBS and lysed in cold modiﬁ ed RIPA buffer (50 mM 
Tris-HCl, pH 7.4, 1% Igepal CA-630, 0.25% deoxycholate, 150 mM 
NaCl, 1 mM EDTA, 1 mM PMSF, 1 mM orthovanadate, 1 mM NaF, and 
1 μg/ml each aprotinin, leupeptin, and pepstatin). Proteins were sepa-
rated by denaturing SDS-PAGE electroblotted onto PVDF, blocked with 5% 
milk in TBS, immunoblotted with speciﬁ c primary antibodies, and detected 
using horseradish peroxidase–conjugated secondary antibodies (Jackson 
ImmunoResearch Laboratories) and SuperSignal West Dura (Pierce Chemi-
cal Co.) as a chemiluminescent substrate. Densitometric analysis was per-
formed using a VersaDoc imaging system with QuantityOne software 
( Bio-Rad Laboratories).
Microfabricated post array detectors
Microfabricated post array detectors (mPADs) were fabricated as previ-
ously described (Lemmon et al., 2005; Tan et al., 2003). mPADs used in 
these studies were 11 μm tall and 3 μm in diameter, with 9 μm center–
center spacing. To control cell spreading on microneedle tips, the tips 
were stamped with ﬁ bronectin using microcontact printing (Tan et al., 
2003), and nonstamped regions were blocked with 0.2% Pluronic F127 
(BASF). ECs expressing either GFP, FRNK, FAK, or FAK-Y397F were cul-
tured on the mPADs for 22 h, after which the samples were ﬁ xed with 4% 
paraformaldehyde in PBS. Fibronectin was stained with goat anti-ﬁ bro-
nectin antibody (ICN Biomedicals) and the nuclei were stained with 
Hoechst 33342. The samples were imaged using an Axiovert 200M 
(Carl Zeiss MicroImaging, Inc.) with the Apotome module, equipped with 
63× Plan-Apochromat, 1.4 NA, oil immersion objective, an Axiocam 
camera, and Axiovision software (Carl Zeiss MicroImaging, Inc.). A Mat-
lab program (The MathWorks) was used to obtain tractional force from 
the acquired images. At least six cells were used in force measurements 
in each condition.
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